Drugdiscovery >> Clinical Trials >> News
3249
Views
Auris medical's first patient entered in Phase III Study for tinnitus - drugdiscovery.com
Auris medical's first patient entered in Phase III Study for tinnitus - drugdiscovery.com


Auris announced that the first patient has entered the clinical trial phase III in Europe.
Read More >>


Tags: europe, PhasII, Auris, Tinnitus - February 24, 2014
Related Articles
5466
Views
Patient enrollment in Phase 3 EPIC trial of Iclusig for CML Patient enrollment in Phase 3 EPIC trial of Iclusig for CML
ARIAD Pharmaceuticals’s drug Iclusig (ponatinib) will be compared for efficasy with imatinib in a Phase 3 trial in adult patients with newly diagnosed chronic myeloid leukemia (CML). ARIAD has enrol Read More >>

Tags: Ariad, iclusig, ponatinib, EPIC, clinical trial, CML, chronic myeloid leukemia

7208
Views
The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate  The results of Phase 1/2 study of Takeda’s norovirus vaccine candidate
The intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adults who were challenged with the most commonly occurring norovirus that causes gastroenteritis showed promise in a Phase 1 Read More >>

Tags: Takeda, vaccine, norovirus, gastroenteritis, clinical trial

7067
Views
 Melflufen enters Phase II study in the treatment of multiple myeloma patients Melflufen enters Phase II study in the treatment of multiple myeloma patients
Melflufen, also known as J1, will be used in combination with dexamethasone for late stage, relapsing or relapsing/refractory patients with multiple myeloma. The aim of this phase study is to determi Read More >>

Tags: melflufen, J1, multiple myeloma, late stage, clinical trial

3165
Views
Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer Promising data from the Phase 3 study of Erbitux in metastatic colorectal cancer
Merck Serono’s Erbitux (cetuximab) plus FOLFIRI, compared to bevacizumab plus FOLFIRI, has shown a clinically relevant improvement (7.5 month increase in median overall survival) as first-line tr Read More >>

Tags: Erbitux, cetuximab, clinical trail, metastatic, colorectal cancer, Merck, cancer therapy

4261
Views
A Phase I/a clinical study of SEPREHVIR  for malignant pleural mesothelioma initiated A Phase I/a clinical study of SEPREHVIR for malignant pleural mesothelioma initiated
Virttu Biologics Limited has announced that the first cohort of patients with inoperable, malignant pleural mesothelioma have been treated with its oncolytic virus- SEPREHVIR in a Phase I/Iia study a Read More >>

Tags: malignant pleural mesothelioma, mesothelioma, clinical trial, Virttu Biologics, oncolytic virus, SEPREHVIR, seprehvir

7145
Views
New succes on Phase II trial of a new GBM vaccine New succes on Phase II trial of a new GBM vaccine
ImmunoCellular Therapeutics Ltd's GBM vaccine proved to be successful on Phase II clinical trial. GBM is one of the most offensive cancer of the brain. There are few therapeutic options for this, so t Read More >>

Tags: GBM, Brain Cancer, ImmunoCellular Therapeutics, Ltd, Phase II. clinical trial.

2942
Views
Interferon-free hepatitis coctail of AbbVie enters Phase III Interferon-free hepatitis coctail of AbbVie enters Phase III
The new drug of AbbVie has entered clinical trial phase II. It cures hepatitis C, and provides a ribavirin-free, all-oral treatment without interferon. Read More >>

Tags: interferon, hepatitis C, clinical trial, Phase III

3850
Views
CCL Clinical trial through the eyes of a patient CCL Clinical trial through the eyes of a patient
ABT-199 is a chronic lymphocytic leukemia (CLL) drug at Phase 1. Harley Hudson is taking part in the trial and hopes to get at least a long term solution for his illness. Read More >>

Tags: solution, illness, CLL, chronic lymphocytic leukemia, clinical trial, cancer

3441
Views
Phase-III trial of new sarcoma drug Phase-III trial of new sarcoma drug
620 patients were enrolled to the Phase-III trial of TH-302. The trial is led by Threshold Pharmaceuticals. The new drug might open a new chapter in the history of advanced soft-tissue sarcoma. Read More >>

Tags: soft tissue sarcoma, phase-III trial, soft tissue

3764
Views
Somatuline successful in the ELECT study Somatuline successful in the ELECT study
Ipsen ELECT study met its primary endpoint, which aimed to assess the effect of Somatuline Injection on the control of symptoms in patients with neuroendocrine tumors (NETs) associated with carcinoid Read More >>

Tags: somatuline, neuroendocrine tumors, carcinoid syndrome

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013